Diclofenac Capsules and Insulin Glargine (U-300) Pens
Determining the interaction of Diclofenac Capsules and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diclofenac
Brand name: Cambia, Cataflam, Voltaren-XR, Zipsor, Zorvolex, Voltaren, Dyloject, also Cambia
Synonyms: Diclofenac, Diclofenac (Systemic)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diclofenac Capsules-Insulin glargine and lixisenatide
- Diclofenac Capsules-Insulin glargine and lixisenatide Subcutaneous
- Diclofenac Capsules-Insulin glargine, recombinant Subcutaneous
- Diclofenac Capsules-Insulin glulisine
- Diclofenac Capsules-Insulin Glulisine (Cartridges and Pens)
- Diclofenac Capsules-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Diclofenac Cream
- Insulin Glargine (U-300) Pens-Diclofenac Delayed-Release Tablets
- Insulin Glargine (U-300) Pens-Diclofenac epolamine
- Insulin Glargine (U-300) Pens-Diclofenac Epolamine Patch
- Insulin Glargine (U-300) Pens-Diclofenac Extended Release Tablets 100mg
- Insulin Glargine (U-300) Pens-Diclofenac Extended-Release Tablets